🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests how well giving dasatinib and quercetin with cycl...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-09-18
Trial ID
NCT06940297
This phase I/II trial studies the side effects and best dose of ABBV-383 an...
Status
Not Yet Recruiting
Location
Mayo Clinic in Rochester
Start Date
2026-10-25
Trial ID
NCT07420959
This phase II trial tests how well decitabine and cedazuridine (DEC-C) work...
Status
Terminated
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2023-04-13
Trial ID
NCT05799079
Treatments Being Tested
Background: The disease follicular lymphoma (FL) develops when the body ma...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2019-08-22
Trial ID
NCT03789240
This phase II/III trial studies how well daunorubicin and cytarabine with o...
Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences
Start Date
2019-03-28
Trial ID
NCT03701308
This phase II clinical trial studies how well treosulfan, thiotepa, fludara...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2021-05-05
Trial ID
NCT03980769
Hematology patients go through many difficult periods during the diagnosis ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-22
Trial ID
NCT07063498
Treatments Being Tested
This study evaluates hematopoiesis to determine how MBL/CLL affected bone m...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2016-11-18
Trial ID
NCT06536452
Treatments Being Tested
Ovarian cancer (OC) is one of the most lethal cancers in the world due to l...
Status
Recruiting
Location
Catharina Hospital
Start Date
2025-01-01
Trial ID
NCT06611072
Treatments Being Tested
This phase II trial studies how well the addition of nemtabrutinib to lisoc...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-09-01
Trial ID
NCT07194980
Treatments Being Tested